Trial Profile

Special Drug Use Investigation for LAMICTAL Bipolar

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lamotrigine (Primary)
Indications Bipolar disorders
Focus Adverse reactions; Therapeutic Use
Sponsors GlaxoSmithKline; GSK

Most Recent Events

15 Aug 2017 Primary endpoint (Time to recurrence/relapse of mood episodes in patients) has been met, as per results published in the Journal of Clinical Psychiatry.
15 Aug 2017 Results (n=966) published in the Journal of Clinical Psychiatry.
21 Apr 2016 Status changed from not yet recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com